COMP and rheumatoid arthritis: However, Takeuchi et al. and So et al. found that denosumab did not affect the cartilage turnover marker serum cartilage oligomeric protein (COMP) (13, 14), indicating that denosumab might have no anti-inflammatory effect on RA patients.